BioSpace News Archive

BioMidwest

SCORR Marketing and Applied Clinical Trials Release Report on Clinical Research Industry Salary and Employee Satisfaction

SCORR Marketing, a global health science marketing and communications firm, has announced that a new Industry Salary and Employee Satisfaction Survey Report is now available for free download.

January 9, 2018
·
1 min read
FDA

WACKER Obtains FDA Approval to Manufacture the Drug Substance in Retavase, a Thrombolysis Medication by Chiesi

Wacker Biotech GmbH will produce the drug substance reteplase, the active ingredient in the drug Retavase, which the pharmaceutical company Chiesi will market in the USA.

January 9, 2018
·
2 min read
Business

BIAL and Wanbang Announce Exclusive Licensing Agreement for Opicapone in China

Under the terms of the agreement, BIAL will receive from Wanbang an upfront license fee of 2.5 million euros and up to 12.5 million euros in further milestones.

January 9, 2018
·
2 min read
Biotech Beach

Otonomy Provides Corporate and Product Pipeline Update - Jan. 9, 2018

The company provided an update on its product pipeline and financial guidance today.

January 9, 2018
·
10 min read
BioForest

Stratos Genomics Raises Funds to Ready for Commercialization

The company has raised $20 million in venture capital from Fisk Ventures.

January 9, 2018
·
2 min read
Business

Alphatec Announces Preliminary Fourth Quarter and Full Year 2017 Revenue and Corporate Updates

The Company also provided several corporate updates.

January 9, 2018
·
8 min read
Zora Expands CERT - A Validated Test for Cardiovascular and Diabetes Risk Prediction

Zora Biosciences Oy has announced the expansion of its CERT to include prediction of type II diabetes.

January 9, 2018
·
2 min read
FDA

Advanced Bionics Announces Health Canada Approval for the New HiFocus SlimJ Electrode

Health Canada approval follows approval by FDA (Food and Drug Administration) in the United States and TÜV (Technical Inspection Authority, Munich, Germany).

January 9, 2018
·
4 min read
Breathtec Biomedical Unaware of Any Material Change

Breathtec confirms that the Company management is unaware of any material change or event with respect to the Company’s operation or activities that would account for the recent increase in market activity and price increase.

January 9, 2018
·
2 min read
DAN-NICADII Study to Expand the Applicability of the Non-Invasive Acarix CADScor System for Rapid Ruling Out Coronary Artery Disease

The results from the extensive study are expected to be available early 2020.

January 9, 2018
·
2 min read